Valente Manuela 4
4 · SOPHiA GENETICS SA · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CPO Manuela Valente Sells 4,241 Shares
What Happened Manuela Valente, Chief People Officer of SOPHiA GENETICS SA (SOPH), sold 4,241 shares on July 6, 2026 in an open-market transaction. The reported weighted-average price was $5.05 per share for total proceeds of approximately $21,430. This was a sale (not a purchase) and appears routine rather than an indicator of a change in company outlook.
Key Details
- Transaction date: July 6, 2026 (Form 4 filed July 7, 2026).
- Shares sold: 4,241; weighted-average price reported: $5.05; total proceeds ≈ $21,430.
- Price range: shares were sold in multiple trades between $4.95 and $5.34 (footnote F2).
- Purpose/footnote: Sales were executed to satisfy tax withholding obligations related to RSU vestings on July 2 and July 3, 2026, and were effected under a pre-established Rule 10b5-1(c) trading plan (footnote F1). The filer indicates these were not discretionary trades.
- Shares owned after transaction: not specified in the provided filing.
- Timeliness: Filing was made the day after the transaction (no late filing flag indicated).
Context These shares were sold to cover tax withholding tied to restricted stock unit vesting — a common, administrative reason for insider sales. The transaction was executed under a 10b5-1 plan, which typically indicates pre-planned, non-discretionary sales. If you want the exact breakdown of how many shares sold at each price within the $4.95–$5.34 range, the filer has offered to provide that detail to the company, security holders, or the SEC staff upon written request.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-07-06$5.05/sh−4,241$21,430→ 210,450 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 2, 2026 and July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.95 to $5.34, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.